- Home
- BFLY vs SGP Comparison
BFLY vs SGP Comparison
Compare BFLY & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFLY | SGP |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | United States |
| Employees | 220 | N/A |
| Industry | Medical Electronics | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 932.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BFLY | SGP |
|---|---|---|
| Price | $4.20 | $21.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $5.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 3.9M | 100.9K |
| Earning Date | 05-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.01 | N/A |
| Revenue Next Year | $19.93 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $20.15 |
| 52 Week High | $5.03 | $30.56 |
Technical Indicators
Market Signals| Indicator | BFLY | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 37.82 |
| Support Level | $3.63 | $21.29 |
| Resistance Level | $4.42 | $28.17 |
| Average True Range (ATR) | 0.26 | 2.17 |
| MACD | -0.00 | -0.34 |
| Stochastic Oscillator | 65.07 | 16.82 |
Price Performance
Historical ComparisonAbout BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.